Pedersen, Anette T.

Serum levels of anti-mullerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients

Hagen, C. P., Aksglaede, L., Sørensen, K., Main, K. M., Boas, M., Cleemann, L., Holm, K., Gravholt, C. H., Andersson, A.-M., Pedersen, A. T., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersSexual Differentiation and Disorders

Cited by 383

The association between early menopause and risk of ischaemic heart disease: influence of hormone therapy

Løkkegaard, E., Jovanovic, Z., Heitmann, B. L., Keiding, N., Ottesen, B., & Pedersen, A. T. (2006) · Maturitas

Menopause: Health Impacts and TreatmentsHormonal and reproductive studies

Cited by 243

AMH as predictor of premature ovarian insufficiency: a longitudinal study of 120 Turner syndrome patients

Lunding, S. A., Aksglaede, L., Anderson, R. A., Main, K. M., Juul, A., Hagen, C. P., & Pedersen, A. T. (2015) · The Journal of Clinical Endocrinology & Metabolism

Genetic and Clinical Aspects of Sex Determination and Chromosomal AbnormalitiesOvarian function and disorders

Cited by 125

Changes in abdominal subcutaneous adipose tissue phenotype following menopause is associated with increased visceral fat mass

Abildgaard, J., Ploug, T., Al-Saoudi, E., Wagner, T., Thomsen, C., Ewertsen, C., Bzorek, M., Pedersen, B. K., Pedersen, A. T., & Lindegaard, B. (2021) · Scientific Reports

Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and Metabolism

Cited by 116